nodes	percent_of_prediction	percent_of_DWPC	metapath
Pirbuterol—Clenbuterol—TNF—pancreatic cancer	0.0114	0.704	CrCbGaD
Pirbuterol—Epinephrine—TNF—pancreatic cancer	0.00478	0.296	CrCbGaD
Pirbuterol—Chest pain—Tamoxifen—pancreatic cancer	0.00421	0.00516	CcSEcCtD
Pirbuterol—Anxiety—Tamoxifen—pancreatic cancer	0.00419	0.00515	CcSEcCtD
Pirbuterol—Dysphonia—Doxorubicin—pancreatic cancer	0.00418	0.00513	CcSEcCtD
Pirbuterol—Stomatitis—Fluorouracil—pancreatic cancer	0.00416	0.00511	CcSEcCtD
Pirbuterol—Chest pain—Erlotinib—pancreatic cancer	0.00416	0.00511	CcSEcCtD
Pirbuterol—Anxiety—Erlotinib—pancreatic cancer	0.00415	0.00509	CcSEcCtD
Pirbuterol—Dry mouth—Tamoxifen—pancreatic cancer	0.00411	0.00505	CcSEcCtD
Pirbuterol—Back pain—Sunitinib—pancreatic cancer	0.00409	0.00503	CcSEcCtD
Pirbuterol—Muscle spasms—Sunitinib—pancreatic cancer	0.00407	0.00499	CcSEcCtD
Pirbuterol—Glossitis—Epirubicin—pancreatic cancer	0.00403	0.00495	CcSEcCtD
Pirbuterol—Oedema—Tamoxifen—pancreatic cancer	0.00403	0.00495	CcSEcCtD
Pirbuterol—Oedema—Erlotinib—pancreatic cancer	0.00399	0.0049	CcSEcCtD
Pirbuterol—Migraine—Docetaxel—pancreatic cancer	0.00394	0.00484	CcSEcCtD
Pirbuterol—Shock—Erlotinib—pancreatic cancer	0.00393	0.00482	CcSEcCtD
Pirbuterol—Anorexia—Tamoxifen—pancreatic cancer	0.00384	0.00472	CcSEcCtD
Pirbuterol—Hypoaesthesia—Fluorouracil—pancreatic cancer	0.00382	0.00468	CcSEcCtD
Pirbuterol—Anorexia—Erlotinib—pancreatic cancer	0.0038	0.00467	CcSEcCtD
Pirbuterol—Glossitis—Doxorubicin—pancreatic cancer	0.00373	0.00458	CcSEcCtD
Pirbuterol—Flushing—Irinotecan—pancreatic cancer	0.00372	0.00456	CcSEcCtD
Pirbuterol—Cough—Sunitinib—pancreatic cancer	0.00369	0.00453	CcSEcCtD
Pirbuterol—Insomnia—Tamoxifen—pancreatic cancer	0.00365	0.00448	CcSEcCtD
Pirbuterol—Insomnia—Erlotinib—pancreatic cancer	0.00361	0.00443	CcSEcCtD
Pirbuterol—Cramp muscle—Docetaxel—pancreatic cancer	0.0036	0.00442	CcSEcCtD
Pirbuterol—Chest pain—Sunitinib—pancreatic cancer	0.0036	0.00442	CcSEcCtD
Pirbuterol—Alopecia—Irinotecan—pancreatic cancer	0.00354	0.00434	CcSEcCtD
Pirbuterol—Dry mouth—Sunitinib—pancreatic cancer	0.00352	0.00433	CcSEcCtD
Pirbuterol—Decreased appetite—Tamoxifen—pancreatic cancer	0.00351	0.0043	CcSEcCtD
Pirbuterol—Fatigue—Tamoxifen—pancreatic cancer	0.00348	0.00427	CcSEcCtD
Pirbuterol—Decreased appetite—Erlotinib—pancreatic cancer	0.00347	0.00426	CcSEcCtD
Pirbuterol—Oedema—Sunitinib—pancreatic cancer	0.00345	0.00424	CcSEcCtD
Pirbuterol—Alopecia—Gemcitabine—pancreatic cancer	0.00345	0.00423	CcSEcCtD
Pirbuterol—Fatigue—Erlotinib—pancreatic cancer	0.00344	0.00422	CcSEcCtD
Pirbuterol—Shock—Sunitinib—pancreatic cancer	0.0034	0.00417	CcSEcCtD
Pirbuterol—Alopecia—Fluorouracil—pancreatic cancer	0.00339	0.00416	CcSEcCtD
Pirbuterol—Back pain—Irinotecan—pancreatic cancer	0.00337	0.00414	CcSEcCtD
Pirbuterol—Muscle spasms—Irinotecan—pancreatic cancer	0.00335	0.00411	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.0033	0.00405	CcSEcCtD
Pirbuterol—Anorexia—Sunitinib—pancreatic cancer	0.00329	0.00404	CcSEcCtD
Pirbuterol—Back pain—Gemcitabine—pancreatic cancer	0.00328	0.00403	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00326	0.00401	CcSEcCtD
Pirbuterol—Abdominal pain—Tamoxifen—pancreatic cancer	0.00319	0.00391	CcSEcCtD
Pirbuterol—Abdominal pain—Erlotinib—pancreatic cancer	0.00315	0.00387	CcSEcCtD
Pirbuterol—Weight increased—Docetaxel—pancreatic cancer	0.00315	0.00386	CcSEcCtD
Pirbuterol—Syncope—Irinotecan—pancreatic cancer	0.00313	0.00384	CcSEcCtD
Pirbuterol—Insomnia—Sunitinib—pancreatic cancer	0.00312	0.00384	CcSEcCtD
Pirbuterol—Loss of consciousness—Irinotecan—pancreatic cancer	0.00306	0.00376	CcSEcCtD
Pirbuterol—Cough—Irinotecan—pancreatic cancer	0.00304	0.00373	CcSEcCtD
Pirbuterol—Stomatitis—Docetaxel—pancreatic cancer	0.00301	0.00369	CcSEcCtD
Pirbuterol—Decreased appetite—Sunitinib—pancreatic cancer	0.003	0.00369	CcSEcCtD
Pirbuterol—Fatigue—Sunitinib—pancreatic cancer	0.00298	0.00366	CcSEcCtD
Pirbuterol—Cough—Gemcitabine—pancreatic cancer	0.00296	0.00364	CcSEcCtD
Pirbuterol—Asthenia—Tamoxifen—pancreatic cancer	0.00289	0.00355	CcSEcCtD
Pirbuterol—Chest pain—Gemcitabine—pancreatic cancer	0.00289	0.00355	CcSEcCtD
Pirbuterol—Confusional state—Irinotecan—pancreatic cancer	0.00287	0.00352	CcSEcCtD
Pirbuterol—Asthenia—Erlotinib—pancreatic cancer	0.00286	0.00351	CcSEcCtD
Pirbuterol—Pruritus—Tamoxifen—pancreatic cancer	0.00285	0.0035	CcSEcCtD
Pirbuterol—Oedema—Irinotecan—pancreatic cancer	0.00284	0.00349	CcSEcCtD
Pirbuterol—Chest pain—Fluorouracil—pancreatic cancer	0.00284	0.00349	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00282	0.00347	CcSEcCtD
Pirbuterol—Pruritus—Erlotinib—pancreatic cancer	0.00282	0.00347	CcSEcCtD
Pirbuterol—Shock—Irinotecan—pancreatic cancer	0.0028	0.00344	CcSEcCtD
Pirbuterol—Oedema—Gemcitabine—pancreatic cancer	0.00277	0.0034	CcSEcCtD
Pirbuterol—Diarrhoea—Tamoxifen—pancreatic cancer	0.00276	0.00339	CcSEcCtD
Pirbuterol—Hypoaesthesia—Docetaxel—pancreatic cancer	0.00275	0.00338	CcSEcCtD
Pirbuterol—Confusional state—Fluorouracil—pancreatic cancer	0.00275	0.00337	CcSEcCtD
Pirbuterol—Abdominal pain—Sunitinib—pancreatic cancer	0.00273	0.00335	CcSEcCtD
Pirbuterol—Diarrhoea—Erlotinib—pancreatic cancer	0.00273	0.00335	CcSEcCtD
Pirbuterol—Oedema—Fluorouracil—pancreatic cancer	0.00272	0.00335	CcSEcCtD
Pirbuterol—Anorexia—Irinotecan—pancreatic cancer	0.00271	0.00333	CcSEcCtD
Pirbuterol—Dizziness—Tamoxifen—pancreatic cancer	0.00267	0.00327	CcSEcCtD
Pirbuterol—Tachycardia—Fluorouracil—pancreatic cancer	0.00266	0.00326	CcSEcCtD
Pirbuterol—Hypotension—Irinotecan—pancreatic cancer	0.00266	0.00326	CcSEcCtD
Pirbuterol—Migraine—Epirubicin—pancreatic cancer	0.00266	0.00326	CcSEcCtD
Pirbuterol—Anorexia—Gemcitabine—pancreatic cancer	0.00264	0.00324	CcSEcCtD
Pirbuterol—Dizziness—Erlotinib—pancreatic cancer	0.00264	0.00324	CcSEcCtD
Pirbuterol—Anorexia—Fluorouracil—pancreatic cancer	0.0026	0.00319	CcSEcCtD
Pirbuterol—Hypotension—Gemcitabine—pancreatic cancer	0.00259	0.00318	CcSEcCtD
Pirbuterol—Insomnia—Irinotecan—pancreatic cancer	0.00257	0.00316	CcSEcCtD
Pirbuterol—Flushing—Docetaxel—pancreatic cancer	0.00257	0.00315	CcSEcCtD
Pirbuterol—Vomiting—Tamoxifen—pancreatic cancer	0.00256	0.00315	CcSEcCtD
Pirbuterol—Hypotension—Fluorouracil—pancreatic cancer	0.00255	0.00313	CcSEcCtD
Pirbuterol—Rash—Tamoxifen—pancreatic cancer	0.00254	0.00312	CcSEcCtD
Pirbuterol—Dermatitis—Tamoxifen—pancreatic cancer	0.00254	0.00312	CcSEcCtD
Pirbuterol—Vomiting—Erlotinib—pancreatic cancer	0.00254	0.00311	CcSEcCtD
Pirbuterol—Somnolence—Irinotecan—pancreatic cancer	0.00253	0.00311	CcSEcCtD
Pirbuterol—Headache—Tamoxifen—pancreatic cancer	0.00253	0.0031	CcSEcCtD
Pirbuterol—Rash—Erlotinib—pancreatic cancer	0.00252	0.00309	CcSEcCtD
Pirbuterol—Dermatitis—Erlotinib—pancreatic cancer	0.00251	0.00309	CcSEcCtD
Pirbuterol—Insomnia—Gemcitabine—pancreatic cancer	0.00251	0.00308	CcSEcCtD
Pirbuterol—Headache—Erlotinib—pancreatic cancer	0.0025	0.00307	CcSEcCtD
Pirbuterol—Asthenia—Sunitinib—pancreatic cancer	0.00248	0.00304	CcSEcCtD
Pirbuterol—Decreased appetite—Irinotecan—pancreatic cancer	0.00247	0.00304	CcSEcCtD
Pirbuterol—Insomnia—Fluorouracil—pancreatic cancer	0.00246	0.00303	CcSEcCtD
Pirbuterol—Somnolence—Gemcitabine—pancreatic cancer	0.00246	0.00302	CcSEcCtD
Pirbuterol—Migraine—Doxorubicin—pancreatic cancer	0.00246	0.00302	CcSEcCtD
Pirbuterol—Fatigue—Irinotecan—pancreatic cancer	0.00245	0.00301	CcSEcCtD
Pirbuterol—Alopecia—Docetaxel—pancreatic cancer	0.00245	0.003	CcSEcCtD
Pirbuterol—Pruritus—Sunitinib—pancreatic cancer	0.00244	0.003	CcSEcCtD
Pirbuterol—Somnolence—Fluorouracil—pancreatic cancer	0.00242	0.00297	CcSEcCtD
Pirbuterol—Decreased appetite—Gemcitabine—pancreatic cancer	0.00241	0.00296	CcSEcCtD
Pirbuterol—Nausea—Tamoxifen—pancreatic cancer	0.0024	0.00294	CcSEcCtD
Pirbuterol—Fatigue—Gemcitabine—pancreatic cancer	0.00239	0.00293	CcSEcCtD
Pirbuterol—Nausea—Erlotinib—pancreatic cancer	0.00237	0.00291	CcSEcCtD
Pirbuterol—Decreased appetite—Fluorouracil—pancreatic cancer	0.00237	0.00291	CcSEcCtD
Pirbuterol—Diarrhoea—Sunitinib—pancreatic cancer	0.00236	0.0029	CcSEcCtD
Pirbuterol—Feeling abnormal—Irinotecan—pancreatic cancer	0.00234	0.00288	CcSEcCtD
Pirbuterol—Back pain—Docetaxel—pancreatic cancer	0.00233	0.00286	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00233	0.00286	CcSEcCtD
Pirbuterol—Muscle spasms—Docetaxel—pancreatic cancer	0.00232	0.00284	CcSEcCtD
Pirbuterol—Dizziness—Sunitinib—pancreatic cancer	0.00228	0.0028	CcSEcCtD
Pirbuterol—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00228	0.0028	CcSEcCtD
Pirbuterol—Abdominal pain—Irinotecan—pancreatic cancer	0.00225	0.00276	CcSEcCtD
Pirbuterol—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00225	0.00276	CcSEcCtD
Pirbuterol—Vomiting—Sunitinib—pancreatic cancer	0.0022	0.0027	CcSEcCtD
Pirbuterol—Rash—Sunitinib—pancreatic cancer	0.00218	0.00267	CcSEcCtD
Pirbuterol—Dermatitis—Sunitinib—pancreatic cancer	0.00218	0.00267	CcSEcCtD
Pirbuterol—Headache—Sunitinib—pancreatic cancer	0.00216	0.00266	CcSEcCtD
Pirbuterol—Syncope—Docetaxel—pancreatic cancer	0.00216	0.00265	CcSEcCtD
Pirbuterol—Palpitations—Docetaxel—pancreatic cancer	0.00213	0.00261	CcSEcCtD
Pirbuterol—Weight increased—Epirubicin—pancreatic cancer	0.00212	0.00261	CcSEcCtD
Pirbuterol—Loss of consciousness—Docetaxel—pancreatic cancer	0.00212	0.0026	CcSEcCtD
Pirbuterol—Cough—Docetaxel—pancreatic cancer	0.0021	0.00258	CcSEcCtD
Pirbuterol—Drowsiness—Epirubicin—pancreatic cancer	0.00208	0.00255	CcSEcCtD
Pirbuterol—Chest pain—Docetaxel—pancreatic cancer	0.00205	0.00252	CcSEcCtD
Pirbuterol—Nausea—Sunitinib—pancreatic cancer	0.00205	0.00252	CcSEcCtD
Pirbuterol—Asthenia—Irinotecan—pancreatic cancer	0.00204	0.00251	CcSEcCtD
Pirbuterol—Stomatitis—Epirubicin—pancreatic cancer	0.00203	0.00249	CcSEcCtD
Pirbuterol—Dry mouth—Docetaxel—pancreatic cancer	0.00201	0.00246	CcSEcCtD
Pirbuterol—Asthenia—Gemcitabine—pancreatic cancer	0.00199	0.00244	CcSEcCtD
Pirbuterol—Confusional state—Docetaxel—pancreatic cancer	0.00198	0.00243	CcSEcCtD
Pirbuterol—Oedema—Docetaxel—pancreatic cancer	0.00197	0.00241	CcSEcCtD
Pirbuterol—Weight increased—Doxorubicin—pancreatic cancer	0.00196	0.00241	CcSEcCtD
Pirbuterol—Pruritus—Gemcitabine—pancreatic cancer	0.00196	0.00241	CcSEcCtD
Pirbuterol—Diarrhoea—Irinotecan—pancreatic cancer	0.00195	0.00239	CcSEcCtD
Pirbuterol—Shock—Docetaxel—pancreatic cancer	0.00193	0.00238	CcSEcCtD
Pirbuterol—Pruritus—Fluorouracil—pancreatic cancer	0.00193	0.00237	CcSEcCtD
Pirbuterol—Drowsiness—Doxorubicin—pancreatic cancer	0.00192	0.00236	CcSEcCtD
Pirbuterol—Tachycardia—Docetaxel—pancreatic cancer	0.00192	0.00236	CcSEcCtD
Pirbuterol—Diarrhoea—Gemcitabine—pancreatic cancer	0.0019	0.00233	CcSEcCtD
Pirbuterol—Dizziness—Irinotecan—pancreatic cancer	0.00188	0.00231	CcSEcCtD
Pirbuterol—Stomatitis—Doxorubicin—pancreatic cancer	0.00188	0.0023	CcSEcCtD
Pirbuterol—Anorexia—Docetaxel—pancreatic cancer	0.00187	0.0023	CcSEcCtD
Pirbuterol—Diarrhoea—Fluorouracil—pancreatic cancer	0.00186	0.00229	CcSEcCtD
Pirbuterol—Hypoaesthesia—Epirubicin—pancreatic cancer	0.00186	0.00228	CcSEcCtD
Pirbuterol—Hypotension—Docetaxel—pancreatic cancer	0.00184	0.00226	CcSEcCtD
Pirbuterol—Vomiting—Irinotecan—pancreatic cancer	0.00181	0.00222	CcSEcCtD
Pirbuterol—Dizziness—Fluorouracil—pancreatic cancer	0.0018	0.00221	CcSEcCtD
Pirbuterol—Rash—Irinotecan—pancreatic cancer	0.00179	0.0022	CcSEcCtD
Pirbuterol—Dermatitis—Irinotecan—pancreatic cancer	0.00179	0.0022	CcSEcCtD
Pirbuterol—Headache—Irinotecan—pancreatic cancer	0.00178	0.00219	CcSEcCtD
Pirbuterol—Insomnia—Docetaxel—pancreatic cancer	0.00178	0.00218	CcSEcCtD
Pirbuterol—Vomiting—Gemcitabine—pancreatic cancer	0.00176	0.00216	CcSEcCtD
Pirbuterol—Somnolence—Docetaxel—pancreatic cancer	0.00175	0.00215	CcSEcCtD
Pirbuterol—Rash—Gemcitabine—pancreatic cancer	0.00175	0.00215	CcSEcCtD
Pirbuterol—Dermatitis—Gemcitabine—pancreatic cancer	0.00175	0.00214	CcSEcCtD
Pirbuterol—Headache—Gemcitabine—pancreatic cancer	0.00174	0.00213	CcSEcCtD
Pirbuterol—Flushing—Epirubicin—pancreatic cancer	0.00173	0.00213	CcSEcCtD
Pirbuterol—Vomiting—Fluorouracil—pancreatic cancer	0.00173	0.00213	CcSEcCtD
Pirbuterol—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.00172	0.00211	CcSEcCtD
Pirbuterol—Rash—Fluorouracil—pancreatic cancer	0.00172	0.00211	CcSEcCtD
Pirbuterol—Dermatitis—Fluorouracil—pancreatic cancer	0.00172	0.00211	CcSEcCtD
Pirbuterol—Decreased appetite—Docetaxel—pancreatic cancer	0.00171	0.0021	CcSEcCtD
Pirbuterol—Headache—Fluorouracil—pancreatic cancer	0.00171	0.0021	CcSEcCtD
Pirbuterol—Fatigue—Docetaxel—pancreatic cancer	0.0017	0.00208	CcSEcCtD
Pirbuterol—Nausea—Irinotecan—pancreatic cancer	0.00169	0.00207	CcSEcCtD
Pirbuterol—Alopecia—Epirubicin—pancreatic cancer	0.00165	0.00203	CcSEcCtD
Pirbuterol—Nausea—Gemcitabine—pancreatic cancer	0.00165	0.00202	CcSEcCtD
Pirbuterol—Feeling abnormal—Docetaxel—pancreatic cancer	0.00162	0.00199	CcSEcCtD
Pirbuterol—Nausea—Fluorouracil—pancreatic cancer	0.00162	0.00199	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00161	0.00197	CcSEcCtD
Pirbuterol—Flushing—Doxorubicin—pancreatic cancer	0.0016	0.00197	CcSEcCtD
Pirbuterol—Tension—Epirubicin—pancreatic cancer	0.00159	0.00196	CcSEcCtD
Pirbuterol—Nervousness—Epirubicin—pancreatic cancer	0.00158	0.00194	CcSEcCtD
Pirbuterol—Back pain—Epirubicin—pancreatic cancer	0.00157	0.00193	CcSEcCtD
Pirbuterol—Muscle spasms—Epirubicin—pancreatic cancer	0.00156	0.00192	CcSEcCtD
Pirbuterol—Abdominal pain—Docetaxel—pancreatic cancer	0.00155	0.00191	CcSEcCtD
Pirbuterol—Alopecia—Doxorubicin—pancreatic cancer	0.00153	0.00187	CcSEcCtD
Pirbuterol—Agitation—Epirubicin—pancreatic cancer	0.00149	0.00183	CcSEcCtD
Pirbuterol—Tension—Doxorubicin—pancreatic cancer	0.00148	0.00181	CcSEcCtD
Pirbuterol—Nervousness—Doxorubicin—pancreatic cancer	0.00146	0.00179	CcSEcCtD
Pirbuterol—Syncope—Epirubicin—pancreatic cancer	0.00146	0.00179	CcSEcCtD
Pirbuterol—Back pain—Doxorubicin—pancreatic cancer	0.00145	0.00179	CcSEcCtD
Pirbuterol—Muscle spasms—Doxorubicin—pancreatic cancer	0.00145	0.00178	CcSEcCtD
Pirbuterol—Palpitations—Epirubicin—pancreatic cancer	0.00144	0.00176	CcSEcCtD
Pirbuterol—Loss of consciousness—Epirubicin—pancreatic cancer	0.00143	0.00175	CcSEcCtD
Pirbuterol—Cough—Epirubicin—pancreatic cancer	0.00142	0.00174	CcSEcCtD
Pirbuterol—Asthenia—Docetaxel—pancreatic cancer	0.00141	0.00173	CcSEcCtD
Pirbuterol—Pruritus—Docetaxel—pancreatic cancer	0.00139	0.00171	CcSEcCtD
Pirbuterol—Chest pain—Epirubicin—pancreatic cancer	0.00138	0.0017	CcSEcCtD
Pirbuterol—Agitation—Doxorubicin—pancreatic cancer	0.00138	0.0017	CcSEcCtD
Pirbuterol—Anxiety—Epirubicin—pancreatic cancer	0.00138	0.00169	CcSEcCtD
Pirbuterol—Dry mouth—Epirubicin—pancreatic cancer	0.00135	0.00166	CcSEcCtD
Pirbuterol—Syncope—Doxorubicin—pancreatic cancer	0.00135	0.00166	CcSEcCtD
Pirbuterol—Diarrhoea—Docetaxel—pancreatic cancer	0.00135	0.00165	CcSEcCtD
Pirbuterol—Confusional state—Epirubicin—pancreatic cancer	0.00134	0.00164	CcSEcCtD
Pirbuterol—Palpitations—Doxorubicin—pancreatic cancer	0.00133	0.00163	CcSEcCtD
Pirbuterol—Oedema—Epirubicin—pancreatic cancer	0.00133	0.00163	CcSEcCtD
Pirbuterol—Loss of consciousness—Doxorubicin—pancreatic cancer	0.00132	0.00162	CcSEcCtD
Pirbuterol—Cough—Doxorubicin—pancreatic cancer	0.00131	0.00161	CcSEcCtD
Pirbuterol—Shock—Epirubicin—pancreatic cancer	0.00131	0.0016	CcSEcCtD
Pirbuterol—Dizziness—Docetaxel—pancreatic cancer	0.0013	0.0016	CcSEcCtD
Pirbuterol—Tachycardia—Epirubicin—pancreatic cancer	0.00129	0.00159	CcSEcCtD
Pirbuterol—Chest pain—Doxorubicin—pancreatic cancer	0.00128	0.00157	CcSEcCtD
Pirbuterol—Anxiety—Doxorubicin—pancreatic cancer	0.00128	0.00157	CcSEcCtD
Pirbuterol—Anorexia—Epirubicin—pancreatic cancer	0.00126	0.00155	CcSEcCtD
Pirbuterol—Dry mouth—Doxorubicin—pancreatic cancer	0.00125	0.00154	CcSEcCtD
Pirbuterol—Vomiting—Docetaxel—pancreatic cancer	0.00125	0.00154	CcSEcCtD
Pirbuterol—Rash—Docetaxel—pancreatic cancer	0.00124	0.00152	CcSEcCtD
Pirbuterol—Hypotension—Epirubicin—pancreatic cancer	0.00124	0.00152	CcSEcCtD
Pirbuterol—Dermatitis—Docetaxel—pancreatic cancer	0.00124	0.00152	CcSEcCtD
Pirbuterol—Confusional state—Doxorubicin—pancreatic cancer	0.00124	0.00152	CcSEcCtD
Pirbuterol—Headache—Docetaxel—pancreatic cancer	0.00123	0.00151	CcSEcCtD
Pirbuterol—Oedema—Doxorubicin—pancreatic cancer	0.00123	0.00151	CcSEcCtD
Pirbuterol—Shock—Doxorubicin—pancreatic cancer	0.00121	0.00148	CcSEcCtD
Pirbuterol—Insomnia—Epirubicin—pancreatic cancer	0.0012	0.00147	CcSEcCtD
Pirbuterol—Tachycardia—Doxorubicin—pancreatic cancer	0.0012	0.00147	CcSEcCtD
Pirbuterol—Somnolence—Epirubicin—pancreatic cancer	0.00118	0.00145	CcSEcCtD
Pirbuterol—Anorexia—Doxorubicin—pancreatic cancer	0.00117	0.00144	CcSEcCtD
Pirbuterol—Nausea—Docetaxel—pancreatic cancer	0.00117	0.00143	CcSEcCtD
Pirbuterol—Decreased appetite—Epirubicin—pancreatic cancer	0.00115	0.00142	CcSEcCtD
Pirbuterol—Hypotension—Doxorubicin—pancreatic cancer	0.00115	0.00141	CcSEcCtD
Pirbuterol—Fatigue—Epirubicin—pancreatic cancer	0.00114	0.0014	CcSEcCtD
Pirbuterol—Insomnia—Doxorubicin—pancreatic cancer	0.00111	0.00136	CcSEcCtD
Pirbuterol—Feeling abnormal—Epirubicin—pancreatic cancer	0.00109	0.00134	CcSEcCtD
Pirbuterol—Somnolence—Doxorubicin—pancreatic cancer	0.00109	0.00134	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00108	0.00133	CcSEcCtD
Pirbuterol—Decreased appetite—Doxorubicin—pancreatic cancer	0.00107	0.00131	CcSEcCtD
Pirbuterol—Fatigue—Doxorubicin—pancreatic cancer	0.00106	0.0013	CcSEcCtD
Pirbuterol—Abdominal pain—Epirubicin—pancreatic cancer	0.00105	0.00129	CcSEcCtD
Pirbuterol—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00101	0.00124	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.001	0.00123	CcSEcCtD
Pirbuterol—Abdominal pain—Doxorubicin—pancreatic cancer	0.00097	0.00119	CcSEcCtD
Pirbuterol—Asthenia—Epirubicin—pancreatic cancer	0.000952	0.00117	CcSEcCtD
Pirbuterol—Pruritus—Epirubicin—pancreatic cancer	0.000938	0.00115	CcSEcCtD
Pirbuterol—Diarrhoea—Epirubicin—pancreatic cancer	0.000908	0.00111	CcSEcCtD
Pirbuterol—Asthenia—Doxorubicin—pancreatic cancer	0.000881	0.00108	CcSEcCtD
Pirbuterol—Dizziness—Epirubicin—pancreatic cancer	0.000877	0.00108	CcSEcCtD
Pirbuterol—Pruritus—Doxorubicin—pancreatic cancer	0.000868	0.00107	CcSEcCtD
Pirbuterol—Vomiting—Epirubicin—pancreatic cancer	0.000843	0.00104	CcSEcCtD
Pirbuterol—Diarrhoea—Doxorubicin—pancreatic cancer	0.00084	0.00103	CcSEcCtD
Pirbuterol—Rash—Epirubicin—pancreatic cancer	0.000836	0.00103	CcSEcCtD
Pirbuterol—Dermatitis—Epirubicin—pancreatic cancer	0.000836	0.00103	CcSEcCtD
Pirbuterol—Headache—Epirubicin—pancreatic cancer	0.000831	0.00102	CcSEcCtD
Pirbuterol—Dizziness—Doxorubicin—pancreatic cancer	0.000812	0.000996	CcSEcCtD
Pirbuterol—Nausea—Epirubicin—pancreatic cancer	0.000788	0.000967	CcSEcCtD
Pirbuterol—Vomiting—Doxorubicin—pancreatic cancer	0.00078	0.000958	CcSEcCtD
Pirbuterol—Rash—Doxorubicin—pancreatic cancer	0.000774	0.00095	CcSEcCtD
Pirbuterol—Dermatitis—Doxorubicin—pancreatic cancer	0.000773	0.000949	CcSEcCtD
Pirbuterol—Headache—Doxorubicin—pancreatic cancer	0.000769	0.000944	CcSEcCtD
Pirbuterol—Nausea—Doxorubicin—pancreatic cancer	0.000729	0.000895	CcSEcCtD
Pirbuterol—ADRB1—Signaling Pathways—GDI1—pancreatic cancer	0.000553	0.00327	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—SSTR3—pancreatic cancer	0.000553	0.00327	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—SSTR1—pancreatic cancer	0.000542	0.0032	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GDI1—pancreatic cancer	0.000541	0.0032	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GDI2—pancreatic cancer	0.000541	0.0032	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PPY—pancreatic cancer	0.000531	0.00314	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—SSTR1—pancreatic cancer	0.00053	0.00313	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—SST—pancreatic cancer	0.000525	0.0031	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—SSTR2—pancreatic cancer	0.000522	0.00308	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PPY—pancreatic cancer	0.00052	0.00307	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—SST—pancreatic cancer	0.000514	0.00304	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—SSTR3—pancreatic cancer	0.000513	0.00303	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—SSTR2—pancreatic cancer	0.00051	0.00301	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—CCKBR—pancreatic cancer	0.000504	0.00298	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—SSTR3—pancreatic cancer	0.000502	0.00297	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—CCKBR—pancreatic cancer	0.000493	0.00291	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—SSTR1—pancreatic cancer	0.000492	0.00291	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—CNR1—pancreatic cancer	0.000485	0.00286	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PPY—pancreatic cancer	0.000483	0.00285	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—SSTR1—pancreatic cancer	0.000481	0.00284	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—CNR1—pancreatic cancer	0.000474	0.0028	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—SSTR2—pancreatic cancer	0.000474	0.0028	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PPY—pancreatic cancer	0.000472	0.00279	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—GCG—pancreatic cancer	0.000468	0.00277	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—SSTR2—pancreatic cancer	0.000463	0.00274	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—GCG—pancreatic cancer	0.000458	0.00271	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CCKBR—pancreatic cancer	0.000457	0.0027	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CCKBR—pancreatic cancer	0.000447	0.00264	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—AGTR1—pancreatic cancer	0.000447	0.00264	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—AGTR1—pancreatic cancer	0.000437	0.00258	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—GAST—pancreatic cancer	0.000433	0.00256	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—GAST—pancreatic cancer	0.000424	0.0025	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—SCT—pancreatic cancer	0.000411	0.00243	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—SCT—pancreatic cancer	0.000402	0.00237	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—GAST—pancreatic cancer	0.000393	0.00232	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—CCK—pancreatic cancer	0.000392	0.00231	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—GAST—pancreatic cancer	0.000385	0.00227	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—CCK—pancreatic cancer	0.000383	0.00226	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—CNR2—pancreatic cancer	0.000382	0.00225	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000382	0.00225	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000376	0.00222	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—CNR2—pancreatic cancer	0.000373	0.00221	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000373	0.00221	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—SCT—pancreatic cancer	0.000373	0.0022	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000367	0.00217	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—SCT—pancreatic cancer	0.000365	0.00215	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PRLHR—pancreatic cancer	0.000357	0.00211	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CCK—pancreatic cancer	0.000356	0.0021	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PRLHR—pancreatic cancer	0.000349	0.00206	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CCK—pancreatic cancer	0.000348	0.00206	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CNR2—pancreatic cancer	0.000347	0.00205	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—GLP1R—pancreatic cancer	0.000347	0.00205	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CCKAR—pancreatic cancer	0.000341	0.00201	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CNR2—pancreatic cancer	0.000339	0.002	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—GLP1R—pancreatic cancer	0.000339	0.002	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—IAPP—pancreatic cancer	0.000338	0.002	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ZNRF3—pancreatic cancer	0.000335	0.00198	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ACVR1B—pancreatic cancer	0.000335	0.00198	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CCKAR—pancreatic cancer	0.000334	0.00197	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—IAPP—pancreatic cancer	0.000331	0.00195	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ZNRF3—pancreatic cancer	0.000328	0.00194	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ACVR1B—pancreatic cancer	0.000328	0.00194	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000325	0.00192	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000318	0.00188	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—SHH—pancreatic cancer	0.000311	0.00184	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—IAPP—pancreatic cancer	0.000307	0.00181	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—SHH—pancreatic cancer	0.000304	0.0018	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—DTX1—pancreatic cancer	0.000303	0.00179	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SSTR3—pancreatic cancer	0.000303	0.00179	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—IAPP—pancreatic cancer	0.0003	0.00177	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—SST—pancreatic cancer	0.000297	0.00175	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—DTX1—pancreatic cancer	0.000297	0.00175	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SSTR3—pancreatic cancer	0.000297	0.00175	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PTCH1—pancreatic cancer	0.000295	0.00174	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PTHLH—pancreatic cancer	0.000295	0.00174	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SSTR1—pancreatic cancer	0.000291	0.00172	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—SST—pancreatic cancer	0.00029	0.00172	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PTCH1—pancreatic cancer	0.000288	0.0017	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PTHLH—pancreatic cancer	0.000288	0.0017	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PPY—pancreatic cancer	0.000285	0.00168	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SSTR1—pancreatic cancer	0.000284	0.00168	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SSTR2—pancreatic cancer	0.00028	0.00165	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PPY—pancreatic cancer	0.000279	0.00165	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—CNR1—pancreatic cancer	0.000274	0.00162	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SSTR2—pancreatic cancer	0.000274	0.00162	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CCKBR—pancreatic cancer	0.00027	0.0016	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—SST—pancreatic cancer	0.00027	0.00159	CbGpPWpGaD
Pirbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000269	0.00159	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—CNR1—pancreatic cancer	0.000268	0.00158	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—GCG—pancreatic cancer	0.000265	0.00156	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CCKBR—pancreatic cancer	0.000264	0.00156	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—SST—pancreatic cancer	0.000264	0.00156	CbGpPWpGaD
Pirbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000263	0.00155	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—GCG—pancreatic cancer	0.000259	0.00153	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—DTX4—pancreatic cancer	0.000254	0.0015	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GLI1—pancreatic cancer	0.000254	0.0015	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000252	0.00149	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CNR1—pancreatic cancer	0.000249	0.00147	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GLI1—pancreatic cancer	0.000249	0.00147	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—DTX4—pancreatic cancer	0.000249	0.00147	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000247	0.00146	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NRP1—pancreatic cancer	0.000247	0.00146	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000247	0.00146	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CNR1—pancreatic cancer	0.000243	0.00144	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NRP1—pancreatic cancer	0.000242	0.00143	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000242	0.00143	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—GCG—pancreatic cancer	0.00024	0.00142	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HEY2—pancreatic cancer	0.000238	0.00141	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—GCG—pancreatic cancer	0.000235	0.00139	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HEY2—pancreatic cancer	0.000233	0.00137	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GAST—pancreatic cancer	0.000232	0.00137	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000229	0.00135	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GAST—pancreatic cancer	0.000227	0.00134	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—AGTR1—pancreatic cancer	0.000224	0.00132	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HEY1—pancreatic cancer	0.00022	0.0013	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SCT—pancreatic cancer	0.00022	0.0013	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SCT—pancreatic cancer	0.000215	0.00127	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HEY1—pancreatic cancer	0.000215	0.00127	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CCK—pancreatic cancer	0.00021	0.00124	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CCK—pancreatic cancer	0.000206	0.00121	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CNR2—pancreatic cancer	0.000205	0.00121	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GLP1R—pancreatic cancer	0.000205	0.00121	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000205	0.00121	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CCKAR—pancreatic cancer	0.000201	0.00119	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CNR2—pancreatic cancer	0.0002	0.00118	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GLP1R—pancreatic cancer	0.0002	0.00118	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—CXCL8—pancreatic cancer	0.0002	0.00118	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CCKAR—pancreatic cancer	0.000197	0.00116	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—JAG2—pancreatic cancer	0.000195	0.00115	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MEN1—pancreatic cancer	0.000193	0.00114	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—JAG2—pancreatic cancer	0.000191	0.00113	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MEN1—pancreatic cancer	0.000188	0.00111	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SHH—pancreatic cancer	0.000184	0.00108	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000183	0.00108	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IAPP—pancreatic cancer	0.000181	0.00107	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SHH—pancreatic cancer	0.00018	0.00106	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NOTCH4—pancreatic cancer	0.000179	0.00105	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IAPP—pancreatic cancer	0.000177	0.00105	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PTHLH—pancreatic cancer	0.000174	0.00103	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PTCH1—pancreatic cancer	0.000174	0.00103	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PTHLH—pancreatic cancer	0.00017	0.00101	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PTCH1—pancreatic cancer	0.00017	0.00101	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SST—pancreatic cancer	0.000159	0.000941	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000157	0.000928	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—JAG1—pancreatic cancer	0.000156	0.000921	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SST—pancreatic cancer	0.000156	0.00092	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000155	0.000917	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000154	0.000908	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—JAG1—pancreatic cancer	0.000152	0.000901	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NOTCH3—pancreatic cancer	0.000152	0.000897	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CNR1—pancreatic cancer	0.000147	0.000868	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CNR1—pancreatic cancer	0.000144	0.000849	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000143	0.000843	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GCG—pancreatic cancer	0.000142	0.000838	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3CG—pancreatic cancer	0.00014	0.000824	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GCG—pancreatic cancer	0.000139	0.00082	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000138	0.000816	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—AGTR1—pancreatic cancer	0.000135	0.0008	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000135	0.000798	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—STK11—pancreatic cancer	0.000133	0.000788	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—AGTR1—pancreatic cancer	0.000132	0.000782	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—STK11—pancreatic cancer	0.000131	0.000771	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000125	0.000741	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000123	0.000725	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.00012	0.000711	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000118	0.000695	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SMAD4—pancreatic cancer	0.000117	0.00069	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000116	0.000683	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SMAD4—pancreatic cancer	0.000114	0.000675	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HES1—pancreatic cancer	0.000114	0.000674	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000113	0.000668	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HES1—pancreatic cancer	0.000112	0.000659	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000109	0.000646	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000107	0.000632	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CXCL8—pancreatic cancer	0.000105	0.00062	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CXCL8—pancreatic cancer	0.000103	0.000607	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TERT—pancreatic cancer	0.0001	0.000591	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TERT—pancreatic cancer	9.78e-05	0.000578	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HIF1A—pancreatic cancer	9.56e-05	0.000565	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TSC2—pancreatic cancer	9.54e-05	0.000564	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HIF1A—pancreatic cancer	9.36e-05	0.000553	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—APOE—pancreatic cancer	9.34e-05	0.000552	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TSC2—pancreatic cancer	9.33e-05	0.000551	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—KDR—pancreatic cancer	9.15e-05	0.00054	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—APOE—pancreatic cancer	9.13e-05	0.000539	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—KDR—pancreatic cancer	8.95e-05	0.000529	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NFKBIA—pancreatic cancer	8.7e-05	0.000514	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NOTCH1—pancreatic cancer	8.62e-05	0.000509	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NFKBIA—pancreatic cancer	8.51e-05	0.000503	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NOTCH1—pancreatic cancer	8.43e-05	0.000498	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3CG—pancreatic cancer	8.43e-05	0.000498	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—NRAS—pancreatic cancer	8.43e-05	0.000498	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—EGF—pancreatic cancer	8.33e-05	0.000492	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3CG—pancreatic cancer	8.24e-05	0.000487	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—NRAS—pancreatic cancer	8.24e-05	0.000487	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—EGF—pancreatic cancer	8.15e-05	0.000481	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—EGFR—pancreatic cancer	7.68e-05	0.000453	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—EGFR—pancreatic cancer	7.51e-05	0.000444	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3CD—pancreatic cancer	7.41e-05	0.000438	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.34e-05	0.000433	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—KRAS—pancreatic cancer	7.25e-05	0.000428	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3CD—pancreatic cancer	7.25e-05	0.000428	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.18e-05	0.000424	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—KRAS—pancreatic cancer	7.09e-05	0.000419	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3CA—pancreatic cancer	6.66e-05	0.000394	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3CA—pancreatic cancer	6.52e-05	0.000385	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3CB—pancreatic cancer	6.46e-05	0.000381	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3CB—pancreatic cancer	6.32e-05	0.000373	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CXCL8—pancreatic cancer	6.2e-05	0.000366	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—HRAS—pancreatic cancer	6.16e-05	0.000364	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CXCL8—pancreatic cancer	6.07e-05	0.000359	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—HRAS—pancreatic cancer	6.03e-05	0.000356	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—AKT1—pancreatic cancer	5.99e-05	0.000354	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CASP3—pancreatic cancer	5.94e-05	0.000351	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—AKT1—pancreatic cancer	5.86e-05	0.000346	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CASP3—pancreatic cancer	5.81e-05	0.000343	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CCND1—pancreatic cancer	5.78e-05	0.000341	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CTNNB1—pancreatic cancer	5.72e-05	0.000338	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CCND1—pancreatic cancer	5.65e-05	0.000334	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MMP9—pancreatic cancer	5.61e-05	0.000331	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CTNNB1—pancreatic cancer	5.6e-05	0.000331	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PTEN—pancreatic cancer	5.58e-05	0.00033	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MMP9—pancreatic cancer	5.49e-05	0.000324	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PTEN—pancreatic cancer	5.46e-05	0.000322	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—AKT1—pancreatic cancer	5.44e-05	0.000322	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—AKT1—pancreatic cancer	5.32e-05	0.000315	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SRC—pancreatic cancer	5.17e-05	0.000306	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SRC—pancreatic cancer	5.06e-05	0.000299	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	5.04e-05	0.000298	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	4.99e-05	0.000295	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	4.98e-05	0.000294	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—VEGFA—pancreatic cancer	4.93e-05	0.000291	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—STAT3—pancreatic cancer	4.88e-05	0.000288	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NRAS—pancreatic cancer	4.87e-05	0.000288	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MYC—pancreatic cancer	4.64e-05	0.000274	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	4.63e-05	0.000273	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MYC—pancreatic cancer	4.54e-05	0.000268	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	4.53e-05	0.000268	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TGFB1—pancreatic cancer	4.52e-05	0.000267	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—EGFR—pancreatic cancer	4.44e-05	0.000262	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	4.28e-05	0.000253	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—KRAS—pancreatic cancer	4.19e-05	0.000248	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	3.94e-05	0.000232	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3CA—pancreatic cancer	3.85e-05	0.000227	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TP53—pancreatic cancer	3.81e-05	0.000225	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TP53—pancreatic cancer	3.72e-05	0.00022	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	3.64e-05	0.000215	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HRAS—pancreatic cancer	3.56e-05	0.00021	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	3.22e-05	0.00019	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—AKT1—pancreatic cancer	3.15e-05	0.000186	CbGpPWpGaD
